ReviewCancers2026

PSMA-Targeted Radioligand Therapy Beyond the Post-Taxane Setting: A Review of Evidence Across the Prostate Cancer Spectrum.

Kaiying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.